J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 67 (1986), 1405-1418; DOI 10.1099/0022-1317-67-7-1405
© 1986 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delmas, B.
Right arrow Articles by Laude, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delmas, B.
Right arrow Articles by Laude, H.
Agricola
Right arrow Articles by Delmas, B.
Right arrow Articles by Laude, H.

Antigenic Structure of Transmissible Gastroenteritis Virus. II. Domains in the Peplomer Glycoprotein

B. Delmas, J. Gelfi and H. Laude

Institut National de la Recherche Agronomique, Station de Recherches de Virologie et d'Immunologie, 78850 Thiverval-Grignon, France

The antigenic structure of the peplomer glycoprotein E2 of the porcine transmissible gastroenteritis coronavirus (TGEV) was explored using a panel of 23 hybridoma antibodies (MAbs). The topography of the epitopes was established by means of a competition radioimmunoassay. Four main antigenic sites, termed A, B, C and D, were thus clearly delineated. Most of the neutralization-mediating determinants were found to cluster in the A-B area, which has been shown to be highly conserved among TGEV strains. Cooperative enhancement of binding to sites B and D was observed following attachment of MAbs relevant to site A. Additional epitopes were identified on E2 by MAbs that selectively recognized its intracellular precursor. Functional mapping was also performed using neutralization-resistant variants. Analysis of their reactivity confirmed part of the epitope linkages defined by the first approach. The overall lower frequency of such variants altered at site A suggested that some of the epitopes may play an essential function.

Keywords: TGEV, coronavirus, peplomer (E2), epitopes

Received 9 January 1986; accepted 27 March 1986.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
H. Pang, Y. Liu, X. Han, Y. Xu, F. Jiang, D. Wu, X. Kong, M. Bartlam, and Z. Rao
Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine
J. Gen. Virol., October 1, 2004; 85(10): 3109 - 3113.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Chen and D. M. Schifferli
Construction, Characterization, and Immunogenicity of an Attenuated Salmonella enterica Serovar Typhimurium pgtE Vaccine Expressing Fimbriae with Integrated Viral Epitopes from the spiC Promoter
Infect. Immun., August 1, 2003; 71(8): 4664 - 4673.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Chen and D. M. Schifferli
Mucosal and Systemic Immune Responses to Chimeric Fimbriae Expressed by Salmonella enterica Serovar Typhimurium Vaccine Strains
Infect. Immun., June 1, 2000; 68(6): 3129 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. Krempl, M.-L. Ballesteros, G. Zimmer, L. Enjuanes, H.-D. Klenk, and G. Herrler
Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants
J. Gen. Virol., February 1, 2000; 81(2): 489 - 496.
[Abstract] [Full Text]


Home page
CVIHome page
D. B. R. Rani, M. E. Bayer, and D. M. Schifferli
Polymeric Display of Immunogenic Epitopes from Herpes Simplex Virus and Transmissible Gastroenteritis Virus Surface Proteins on an Enteroadherent Fimbria
Clin. Vaccine Immunol., January 1, 1999; 6(1): 30 - 40.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1986 by the Society for General Microbiology.